Medication-Assisted Treatment (MAT) is the most effective intervention available for opioid use disorder — and one of the most misunderstood. This guide explains exactly what MAT is, how each medication works, who qualifies, and how to access MAT at InnerCalm Recovery in Jamaica, NY. At InnerCalm Recovery, we specialize in medication assisted treatment Jamaica NY services in Jamaica, Queens NY.
What Is Medication-Assisted Treatment (MAT)?
Medication-Assisted Treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders, primarily opioid use disorder (OUD) and alcohol use disorder (AUD). The goal of MAT is to reduce withdrawal symptoms, eliminate cravings, block the euphoric effects of opioids, and allow patients to stabilize and engage fully in therapy and recovery. MAT is not replacing one drug with another — it is using evidence-based medicine to normalize brain chemistry disrupted by prolonged substance use.
The 3 FDA-Approved MAT Medications for Opioid Use Disorder
1. Buprenorphine (Suboxone, Sublocade, Brixdi). Buprenorphine is a partial opioid agonist — it activates opioid receptors enough to eliminate withdrawal and cravings without producing significant euphoria. Available as a daily sublingual film (Suboxone), a monthly injectable (Sublocade), or a 6-month implant (Brixdi). No prior authorization required for buprenorphine under New York Medicaid. InnerCalm Recovery prescribes buprenorphine and manages ongoing treatment in our Jamaica, NY clinic.
2. Naltrexone (Vivitrol). Naltrexone is a full opioid antagonist — it blocks all opioid receptors completely, preventing any euphoric effect from opioids or alcohol. Available as a daily oral tablet or a monthly injectable (Vivitrol). Requires complete opioid detoxification before starting (typically 7 to 10 days opioid-free). Ideal for patients who are fully detoxed and highly motivated to abstain. InnerCalm Recovery offers Vivitrol injections as part of our Medication-Assisted Treatment program.
3. Methadone. Methadone is a full opioid agonist that fully activates opioid receptors, eliminating withdrawal and cravings with daily dosing. Highly effective, particularly for patients with long-term severe opioid use disorder. Must be dispensed through a federally licensed Opioid Treatment Program (OTP) — not prescribed in a standard outpatient setting. InnerCalm Recovery can provide referrals to licensed methadone programs in the Jamaica, Queens area.
MAT for Alcohol Use Disorder
Medication-Assisted Treatment is also effective for alcohol use disorder. FDA-approved options include naltrexone (oral or Vivitrol injection), which significantly reduces alcohol cravings and the risk of heavy drinking relapse; acamprosate (Campral), which reduces post-acute withdrawal symptoms and supports abstinence; and disulfiram (Antabuse), which causes a severe physical reaction when alcohol is consumed, creating a strong deterrent. InnerCalm Recovery prescribes all three medications and manages ongoing monitoring and dose adjustment.
Who Qualifies for MAT?
You qualify for Medication-Assisted Treatment if you have a diagnosed opioid use disorder or alcohol use disorder. There is no minimum or maximum use history required. You do not need to have failed other treatments first. You do not need to have attempted abstinence on your own. A clinical assessment at InnerCalm Recovery determines which medication is most appropriate for your specific history, current health, and treatment goals. Most patients are able to begin medication on the day of their intake appointment.
Is MAT Effective? What the Evidence Shows
The evidence for Medication-Assisted Treatment is overwhelming. According to SAMHSA, MAT decreases opioid use, reduces the transmission of infectious disease, improves social functioning, and significantly reduces mortality — including a 50 percent or greater reduction in overdose deaths among patients who remain on buprenorphine or methadone. The World Health Organization lists methadone and buprenorphine as essential medicines. The American Society of Addiction Medicine and the American Medical Association both recommend MAT as the standard of care for opioid use disorder. For more information, visit SAMHSA’s official MAT resource at samhsa.gov/medication-assisted-treatment.
Common Myths About MAT — Debunked
Myth: MAT is just trading one addiction for another. Fact: Physical dependence on a medication is not addiction. Addiction is characterized by compulsive use despite harm. Patients on MAT take their medication as prescribed, function normally, and improve dramatically in every quality-of-life measure. The same criticism is never applied to insulin for diabetes or antihypertensives for high blood pressure.
Myth: You have to be off all opioids to start MAT. Fact: Buprenorphine and methadone can be initiated while a patient is still using — in fact, starting buprenorphine requires the patient to be in mild-to-moderate withdrawal, which often means same-day induction. Naltrexone is the only MAT medication that requires full detoxification first.
Myth: MAT is only for severe addiction. Fact: MAT is appropriate across the spectrum of opioid and alcohol use disorder severity. Early intervention with MAT produces better outcomes and prevents escalation to severe dependence.
How to Start MAT at InnerCalm Recovery in Jamaica, NY
Starting Medication-Assisted Treatment at InnerCalm Recovery is straightforward: Call us at (855) 586-7692 to schedule your intake assessment. Same-week appointments are available. We verify your insurance benefits before your first visit. At intake, a licensed physician evaluates your history and recommends the most appropriate MAT medication. Most patients receive their first prescription or injection on day one. We accept Medicaid, Medicare, and most commercial insurance. No referral required.
Frequently Asked Questions About Medication-Assisted Treatment
Q: How long do I stay on MAT? A: SAMHSA recommends at least 12 months of MAT for opioid use disorder. Many patients benefit from longer-term or indefinite maintenance. Your clinical team at InnerCalm Recovery determines duration based on your individual progress — not insurance timelines.
Q: Can I work while on MAT? A: Yes. The vast majority of patients on buprenorphine or naltrexone maintain full-time employment. These medications do not impair cognition or physical function when taken as prescribed.
Q: What does MAT cost with Medicaid? A: For most Medicaid recipients in New York, MAT is covered at little to no out-of-pocket cost. InnerCalm Recovery is in-network with most New York Medicaid plans. Call (855) 586-7692 and we verify your benefits in under 10 minutes.
Medication-Assisted Treatment works. The science is clear. The path is clear. The only question is when you are ready to take it. Call InnerCalm Recovery at (855) 586-7692. Jamaica, NY. Most insurance accepted.